Company intelligence / Profile preview

SNT Biotech

Plainfield, Illinois, United Statessntbiotech.com ↗

Ownership: Private
Development stage: Commercial

Overview

SNT Biotech provides a range of at-home and clinical diagnostic testing solutions, including FIT colon cancer screening, HbA1c diabetes monitoring, UTI PCR testing, STI PCR testing, and comprehensive biometric screenings. The company is recognized for its rapid shipping, regulatory compliance with FDA/CDC guidelines, national reach in the US market, and commitment to health equity through minority/women ownership.

Therapeutic areas: OtherOncologyEndocrinologyInfectious Diseases
Modalities: Diagnostic test kitPCR-based diagnostic testAt-home screening test kit
Industry: Molecular Diagnostics

Drug pipeline

2 assets

FIT Test

Commercial

Indications: Colorectal cancer screening

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on SNT Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SNT Biotech.

Explore the full profile